(PCT) Purecycle Technologies - Overview
Stock: Recycled Polypropylene, Ultra-Pure Resin
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 96.0% |
| Relative Tail Risk | -16.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | -17.64 |
| Character TTM | |
|---|---|
| Beta | 2.214 |
| Beta Downside | 2.323 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.73% |
| CAGR/Max DD | 0.08 |
Description: PCT Purecycle Technologies January 13, 2026
PureCycle Technologies, Inc. (NASDAQ:PCT) commercializes a patented process that converts post-consumer polypropylene (PP) waste into “PureFive,” an ultra-pure recycled PP resin that rivals virgin material in color, odor and performance. The resin is marketed for packaging, labeling, textiles and molded-part applications across consumer and industrial sectors. Founded in 2015 and based in Orlando, Florida, PureCycle holds an exclusive license to operate this technology.
Key industry metrics that shape PureCycle’s outlook include: (1) the global PP market, valued at roughly $150 billion in 2023, which is projected to grow 3-4 % annually driven by packaging demand; (2) the U.S. recycling rate for PP, currently under 5 %, indicating substantial upside for feedstock availability as regulatory pressure on single-use plastics intensifies; and (3) PureCycle’s pilot plant capacity of ~30 kt/yr, with a planned commercial scale-up to >200 kt/yr by 2026, a scale that would allow the company to capture a meaningful share of the emerging “virgin-like” recycled resin premium.
If you’re looking for a data-rich platform to track PureCycle’s financials, competitive positioning, and ESG impact, a quick dive into ValueRay’s analyst toolkit can provide the granular metrics you need to assess the investment case.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -228.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.20 > 0.02 and ΔFCF/TA 4.60 > 1.0 |
| NWC/Revenue: 2598 % < 20% (prev 160.1%; Δ 2438 % < -1%) |
| CFO/TA -0.15 > 3% & CFO -145.9m > Net Income -228.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (184.6m) vs 12m ago 10.83% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.64% > 50% (prev 3.42%; Δ -2.79% > 0%) |
| Interest Coverage Ratio: -2.56 > 6 (EBITDA TTM -131.7m / Interest Expense TTM 64.1m) |
Altman Z'' -3.80
| A: 0.15 (Total Current Assets 265.4m - Total Current Liabilities 118.4m) / Total Assets 989.1m |
| B: -0.81 (Retained Earnings -797.2m / Total Assets 989.1m) |
| C: -0.18 (EBIT TTM -164.4m / Avg Total Assets 889.0m) |
| D: -0.87 (Book Value of Equity -797.2m / Total Liabilities 920.9m) |
| Altman-Z'' Score: -3.80 = D |
What is the price of PCT shares?
Over the past week, the price has changed by +0.94%, over one month by +2.01%, over three months by +0.42% and over the past year by +11.95%.
Is PCT a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PCT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.2 | 57.2% |
| Analysts Target Price | 15.2 | 57.2% |
| ValueRay Target Price | 9.6 | -0.3% |
PCT Fundamental Data Overview February 03, 2026
P/S = 304.3633
P/B = 25.2524
Revenue TTM = 5.66m USD
EBIT TTM = -164.4m USD
EBITDA TTM = -131.7m USD
Long Term Debt = 355.3m USD (from longTermDebt, last quarter)
Short Term Debt = 23.8m USD (from shortTermDebt, last quarter)
Debt = 731.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 493.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.22b USD (1.72b + Debt 731.4m - CCE 237.9m)
Interest Coverage Ratio = -2.56 (Ebit TTM -164.4m / Interest Expense TTM 64.1m)
EV/FCF = -11.37x (Enterprise Value 2.22b / FCF TTM -195.0m)
FCF Yield = -8.80% (FCF TTM -195.0m / Enterprise Value 2.22b)
FCF Margin = -3445 % (FCF TTM -195.0m / Revenue TTM 5.66m)
Net Margin = -4036 % (Net Income TTM -228.5m / Revenue TTM 5.66m)
Gross Margin = unknown ((Revenue TTM 5.66m - Cost of Revenue TTM 112.0m) / Revenue TTM)
Tobins Q-Ratio = 2.24 (Enterprise Value 2.22b / Total Assets 989.1m)
Interest Expense / Debt = 2.22% (Interest Expense 16.2m / Debt 731.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -129.9m (EBIT -164.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.24 (Total Current Assets 265.4m / Total Current Liabilities 118.4m)
Debt / Equity = 10.72 (Debt 731.4m / totalStockholderEquity, last quarter 68.2m)
Debt / EBITDA = -3.75 (negative EBITDA) (Net Debt 493.5m / EBITDA -131.7m)
Debt / FCF = -2.53 (negative FCF - burning cash) (Net Debt 493.5m / FCF TTM -195.0m)
Total Stockholder Equity = 146.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -25.70% (Net Income -228.5m / Total Assets 989.1m)
RoE = -156.0% (Net Income TTM -228.5m / Total Stockholder Equity 146.4m)
RoCE = -32.77% (EBIT -164.4m / Capital Employed (Equity 146.4m + L.T.Debt 355.3m))
RoIC = -25.34% (negative operating profit) (NOPAT -129.9m / Invested Capital 512.6m)
WACC = 10.40% (E(1.72b)/V(2.45b) * Re(14.07%) + D(731.4m)/V(2.45b) * Rd(2.22%) * (1-Tc(0.21)))
Discount Rate = 14.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 6.04%
Fair Price DCF = unknown (Cash Flow -195.0m)
EPS Correlation: -28.13 | EPS CAGR: 7.18% | SUE: 0.92 | # QB: 1
Revenue Correlation: 45.43 | Revenue CAGR: 29.21% | SUE: -0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.21 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=-0.73 | Chg30d=-0.036 | Revisions Net=-3 | Growth EPS=+39.1% | Growth Revenue=+723.9%